y 27632 has been researched along with Cancer of Pancreas in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cutiongco, MF; Gadegaard, N; Jagiełło, A; Kamphorst, JJ; Mackay, G; McGarry, L; Michalopoulou, E; Munro, J; Olson, MF; Pajic, M; Rath, N; Sumpton, D; Timpson, P; Unbekandt, M; Vennin, C | 1 |
Dwinell, MB; Hauser, AD; Roy, I; Williams, CL; Wilson, JM; Zimmerman, NP | 1 |
Andrianov, G; Astsaturov, I; Banina, E; Beglyarova, N; Behrens, D; Bobrov, E; Gabitova, L; Golemis, EA; Hoffman, JP; Jablonski, SA; Khazak, V; Lysenko, E; Mukhamadeeva, R; Paz, K; Pressman, M; Restifo, D; Serebriiskii, IG; Skobeleva, N; Weiner, LM; Zhou, Y | 1 |
Bi, Y; Liu, X | 1 |
Adachi, S; Hanamatsu, T; Hirose, Y; Kawaguchi, J; Kozawa, O; Moriwaki, H; Nakashima, M; Okano, Y; Yamauchi, T; Yasuda, I; Yoshioka, T | 1 |
5 other study(ies) available for y 27632 and Cancer of Pancreas
Article | Year |
---|---|
Rho Kinase Inhibition by AT13148 Blocks Pancreatic Ductal Adenocarcinoma Invasion and Tumor Growth.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 2-Hydroxyphenethylamine; Amides; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Disease Models, Animal; Female; HEK293 Cells; Humans; Male; Mice; Neoplasm Invasiveness; Pancreatic Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Pyrazoles; Pyridines; rho-Associated Kinases; Signal Transduction | 2018 |
Cyclic AMP regulates the migration and invasion potential of human pancreatic cancer cells.
Topics: 1-Methyl-3-isobutylxanthine; Amides; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Deoxycytidine; Enzyme Inhibitors; Gemcitabine; Humans; Neoplasm Invasiveness; Pancreatic Neoplasms; Phosphodiesterase Inhibitors; Pyridines; Quinolones; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; rhoC GTP-Binding Protein; Vasodilator Agents | 2015 |
Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer.
Topics: Amides; Animals; Carcinoma, Pancreatic Ductal; Cell Line; Cell Line, Tumor; Cell Proliferation; Diterpenes; DNA Helicases; DNA-Binding Proteins; Epoxy Compounds; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Mice; Mice, SCID; NIH 3T3 Cells; Pancreatic Neoplasms; Phenanthrenes; Proto-Oncogene Proteins c-myc; Pyridines; rho-Associated Kinases; Signal Transduction; Transcription, Genetic | 2016 |
Y-27632 Increases Sensitivity of PANC-1 Cells to EGCG in Regulating Cell Proliferation and Migration.
Topics: Amides; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Synergism; Humans; Pancreatic Neoplasms; PPAR alpha; Pyridines; RNA, Messenger | 2016 |
Inhibition of Rho-associated coiled-coil containing protein kinase enhances the activation of epidermal growth factor receptor in pancreatic cancer cells.
Topics: Amides; Antibodies, Neutralizing; Carcinoma; Cell Line, Tumor; Cell Proliferation; Drug Evaluation, Preclinical; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Humans; Pancreatic Neoplasms; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; Up-Regulation | 2011 |